References
- 1. Brunton L.L., Lazo J.S., Parker K.L.: Goodman and Gilman’s: the pharmacological basis of therapeutics, 11th ed. New York: McGraw-Hill, 2006.
- 2. Campos-Aldrete M.E., Villafuerte-Robles L.: Influence of the viscosity grade and particle size of HPMC on metronidazole release from matrix tablets. Eur. J. Pharm. Biopharm., 43, 173, 1997.
- 3. Draper N.R., Smith H.: Applied Regression Analysis, John Wiley & Sons Inc., 1998
- 4. Evonik. Eudragit® Application Guidelines, http://eudragit.evonik.com/, 2009.
- 5. Godfrey R., Edwards R.: A chromatographic and spectroscopic study of photo-degraded metronidazole in aqueous solution. J. Pharm. Sci., 80, 212, 1991.
- 6. Gupta V.K. et al.: A novel pH- and time-based multi-unit potential colonic drug delivery system. II. Optimization of multiple response variables. Int. J. Pharm., 213, 93, 2001.
- 7. ICH Guideline. Q2 (R1) (2005) Validation of analytical procedures: text and methodology. International Conference on Harmonization. Vol. 6. 1996.
- 8. Lehmann K., Dreher D.: Mischbarkeit wässriger Poly(meth) acrylat-Dispersionen für Arzneimittelüberzüge. Pharmaz. Ind., 48,1182,1986.
- 9. Lindenberg M., Kopp S., Dressma J.B.: Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur. J. Pharm. Biopharm., 58, 265, 2004.
- 10. Moore J.W., Flanner H.H.: Mathematical comparison of curves with emphasis on in vitro dissolution profiles. Pharm. Techn., 20, 64, 1996.
- 11. Moustafine R.I. et al.: Drug release modification by Interpolymer interaction between countercharged types of Eudragit RL 30D and FS 30D in double - layer films. Int. J. Pharm., 439,17, 2012.
- 12. Mustafin R.I.: Interpolymer Combinations of Chemically Complementary Grades of Eudragit copolymers: A new direction in the design of peroral solid dosage forms of drug delivery systems with controlled release (review). Pharm. Chem. J., 45, 285, 2011.
- 13. Otsuka M., Matsuda Y.: Effect of co-grinding time on the release of pentoxyfylline from waxy matrix tablets. J. Pharm. Sci., 83, 956, 1994.
- 14. Ozyazici M., Gökçe E.H., Ertan G.: Release and diffusional modelling of metronidazole lipid matrices. Eur. J. Pharm. Biopharm., 63, 331, 2006.
- 15. Remington J.P.: Remington: The science and practice of pharmacy. Eds. David B. Troy, and Paul Beringer. Vol. 1. Lippincott Williams & Wilkins, electronic version. London: Pharmaceutical Press, 2006.
- 16. Sato H. et al.: Dissolution mechanism of diclofenac sodium from wax matrix granules. J. Pharm. Sci., 86, 929, 1997.
- 17. Serra L., Domenech J., Peppas N.A.: Drug transport mechanism and release kinetics from molecularly designed poly(acrylic acid-gethylene glycol) hydrogels. Biomaterials, 27, 5440, 2006.
- 18. Shi D. (ed.). Biomedical devices and their applications. Springer, 2004.
- 19. Siepmann J., Peppas N.A.: Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev., 48, 139, 2001.
- 20. Szente V, Baska F, Zelkó R, Suvegh K. Prediction of the drug release stability of different polymeric matrix tablets containing metronidazole. J. Pharm. Biomed. Anal., 54(4): 730-4, 2011.
- 21. The Merck Index. Fourteenth Edition, Whitehouse Station, NJ: Merck & Co., electronic version, 2006.
- 22. United States Pharmacopoeia/National Formulary, 32/27, Rockville, MD: Pharmacopeial Convention; 2009
- 23. Viridén A. et al.: Model drug release from matrix tablets composed of HPMC with different substituent heterogeneity. Int. J. Pharm., 401, 60, 2010.
- 24. Viridén A., Wittgren B., Larsson A.: Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets. Eur. J. Pharm. Sci., 36, 297, 2009.
- 25. Zhang Y. et al.: DDSolver: An add-in program for modeling and comparison of drug dissolutions profiles. AAPS J, 12, 263, 2010.